ABBVIE, INC. for ABBVIE INC.
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Proposals to reform domestic and international tax structures Implementation of the Puerto Rico Oversight, Management, and Economic Stability Act Tax Reform House Republican Tax Reform Blueprint President Tax Reform Principles Senate Tax Reform Efforts Joint Statement on Tax Reform Tax Reform Unified Framework H.R. 1, Bill to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (bill formerly known as the Tax Cuts and Jobs Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Copyright/Patent/Trademark CPT
S. 124: Preserve Access to Affordable Generics Acts S. 1390: STRONGER Patents Act S. 1681: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services H.R. 4117: Competitive Deals Resulting in Unleashed Generics and Savings Act of 2017 or the Competitive DRUGS Act of 2017 - Patent settlements: Biopharmaceutical innovation and patent policy issues Patent litigation reform issues and issues related to post-grant proceedings at the PTO Bayh-Dole march-in rights policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Health Issues HCR
S. 64: Safe and Affordable Drugs from Canada Act of 2017 S. 92: Safe and Affordable Drugs from Canada Act of 2017 S. 297: Increasing Competition in Pharmaceuticals Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 771: Improving Access to Affordable Prescription Drugs Act S. 1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017 H.R. 749: Lower Drug Costs Through Competition Act H.R. 1231: RACE for Children Act S. 456: RACE for Children Act H.R. 1245: Affordable and Safe Prescription Drug Importation Act H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 H.R. 1628: American Health Care Act of 2017 H.R. 1776: Improving Access to Affordable Prescription Drugs Act Prescription Drug User Fee Act (PDUFA) reauthorization Biologics User Fee Act (BsUFA) reauthorization 340B drug discount program policy issues Orphan Drug Act policy issues Biologics Price Competition and Innovation Act (BPCIA) implementation issues Patient assistance program policy issues H.R. 2430: FDA Reauthorization Act of 2017 - Provisions related to user fee programs PL 114-255: 21st Century Cures, implementation H.R. 749: Lower Drug Costs Through Competition Act H.R.2430/S.934: FDA Reauthorization Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act S. 1827: KIDS Act of 2017 H.R. 1703: Medical Product Communications Act of 2017 H.Res. 403: Supporting the designation of March 2018 as Endometriosis Awareness Month
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Medicare/Medicaid MMM
S. 41: Medicare Prescription Drug Price Negotiation Act of 2017 S. 251: Protecting Medicare from Executive Action Act of 2017 S. 260: Protecting Seniors' Access to Medicare Act of 2017 H.R. 242: Medicare Prescription Drug Price Negotiation Act of 2017 H.R. 849: Protecting Seniors' Access to Medicare Act of 2017 H.J.Res. 51: Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act S.J.Res. 16: A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act S.J.Res. 17: A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act Part D policy issues including non-interference and rebates policy issues Center for Medicare and Medicaid Innovation (CMMI) transparency and other policy issues payment methodologies H.R. 3921: HEALTHY KIDS Act - Funding for the Childrens Health Insurance Program S. 1827: KIDS Act of 2017 - Funding for the Childrens Health Insurance Program H.R. 3922: Championing Healthy Kids Act - CHIP and CHC reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Budget/Appropriations BUD
H.R.1370: Continuing Resolution through January 19, 2018 H.R. 2810: National Defense Authorization Act for Fiscal Year 2018 H.J.Res 123: Continuing Resolution through December 22, 2017 H.R.2998: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018 S. 1519: National Defense Authorization Act for Fiscal Year 2018 S.0000: Department of Defense (Chairmans Mark) - Making appropriations for the Department of Defense for the fiscal year ending September 30, 2018 S.0000: Department of Homeland Security (Chairmans Mark) - Making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2018, and for other purposes. H.R. 244: Consolidated Appropriations Act of 2017 S. Con. Res. 25: Senate Budget Resolution H. Res 553: House Budget Resolution
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Trade (domestic/foreign) TRD
U.S. Trade policy, including IP and pharmaceutical market access issues U.S. IP policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Disaster Planning/Emergencies DIS
Issues related to Puerto Rico
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| JOHN P. FORD | — |
| COURTNEY PIRON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.